Deruxtecan is an ADC drug-linker conjugate composed of the cleavable glycine–glycine–phenylalanine–glycine tetrapeptide-based linker, a self-immolative amino methylene spacer, and a novel topoisomerase 1 inhibitor payload that is a derivative of exatecan
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Deruxtecan is an ADC drug-linker conjugate composed of the cleavable glycine–glycine–phenylalanine–glycine tetrapeptide-based linker, a self-immolative amino methylene spacer, and a novel topoisomerase 1 inhibitor payload that is a derivative of exatecan (DX-8951).
[1] A Yver, et al. Ann Oncol . 2020 Mar;31(3):430-434.
6-Maleimidohexanoic acid N-hydroxysuccinimide ester (EMCS)
¥300.00 ¥375.00
没有评价数据